CAU Scholar's Space: Cheon, Young Soon

Detailed Information

Cheon, Young Soon (전영순)

경영경제대학 (경영학부(서울))

Research Area

Tel 02-820-5572
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

IFRS:4||가치관련성:4||corporate governance:3||earnings quality:3||재량적발생액:3||품질관리감리:3||foreign ownership:3||주가반응:3||정보비대칭:3||이익조정:3||Operating income:2||국제회계기준(IFRS):2||재무제표 재작성:2||전기오류수정손익:2||Asset revaluation:2||연결재무제표:2||value relevance:2||Information Asymmetry:2||information asymmetry:2||기업지배구조:2||Quality Control Inspection:2||감사품질:2||내부자거래:2||외국인지분율:2||외국인투자자:2||Informativeness of revaluation:2||discretionary accruals:2||institutional investors:2||Revaluation incentives:2||management earnings forecasts:2||earnings management:2||EARNINGS:1||Earnings announcement:1||Engagement Performance Review:1||FSS guideline:1||Fair Disclosure:1||Financial analysts:1||Forecasting Abilities:1||Foreign Ownership:1||Foreign investors:1||Forward looking Strategies:1||Growth Opportunities:1||IFRS Preparatory Period:1||IFRS 도입준비기간:1||IFRS 시스템구축서비스:1||IFRS 재무보고의 질:1||IFRSrelated Nonaudit Services:1||Information Quality:1||Information advantage:1||Information asymmetry:1||Initial public offerings:1||Insider Trading:1||Insider selling:1||Interest and dividend received:1||Interest paid:1||International Financial Reporting Standards(IFRS):1||KIFRS:1||KASB Statement No.1:1||KOSDAQ firms:1||KOSDAQmarket firms:1||KOSPImarket firms:1||Korean Accounting Association:1||Lockup provision:1||MARKET REACTION:1||Mandatory Adoption:1||Market Reaction:1||Market Reactions to Target Price Revisions:1||Momentum strategy:1||Operating activities:1||Overinvestment:1||PREDISCLOSURE INFORMATION:1||Persistent:1||Personal Profit Hypothesis:1||Quality Control Strength:1||Quality Control System:1||Quality Control System Review:1||Quality of IFRS Financial Reporting:1||Quarterly earnings management:1||R&D capitalization:1||R&D expenditures:1||REA against loss:1||REA for growth:1||Real activities management:1||Reg FD:1||Registration of Accounting Firms:1||Regulation:1||Regulatory inspections:1||Retained Earnings:1||Signaling Hypothesis:1||Statutory Inspection:1||TRADING VOLUME:1||Target Price:1||The 40th Anniversary:1||The DART system:1||Unexpected earnings:1||Value relevance:1||Valuerelevance:1||Voting rights:1||accounting fraud:1||accountingchange:1||accuracy:1||acquisition method:1||actual earnings announcements:1||administrative issue:1||affiliated merger:1||agency problem of management:1||agency problem of nonexecutive directors:1||announcement to call shareholder meeting:1||audit committee:1||audit engagement:1||audit failure:1||audit opinion:1||audit quality:1||audit risk:1||bias:1||biopharmaceutical firm:1||board of directors:1||business combinations:1||common control:1||confirmation:1||consolidated financial statements:1||controlling owners:1||core restatement.:1||credit rating(s):1||date of shareholder meeting:1||deficiencies:1||determinants of goodwill:1||disclosure of fiscal year change:1||domestic institutional ownership:1||earnings information:1||earnings persistence:1||earnings response coefficient:1||explanatory paragraphs:1||fair value:1||firm characteristics:1||firm value:1||foreign investors:1||future stock returns:1||goodwill impairment:1||goodwill overstatement:1||growth opportunities.:1||high－tech growth firm:1||incentive for fiscal year change:1||incomedecreasing restatement:1||information asymmetry theory:1||information effects:1||information uncertainty:1||insider purchase trading:1||insider trading:1||institutional ownership:1||large business group:1||management forecast:1||market efficiency:1||market reaction:1||market reactions:1||milestone disclosure:1||monitoring:1||monitoringmechanism:1||nonaffiliated merger:1||nonmarketable securities:1||opportunistic incentive:1||overestimation:1||overseas subsidiaries:1||ownermanager:1||predecessor book value method:1||preempt:1||preliminary earnings announcement:1||preliminary earnings announcements:1||prior period error corrections:1||priorperiod error corrections:1||professional scepticism:1||proprietary cost theory:1||quality control system:1||rational business decision:1||restatement:1||restatement of financial statements:1||retained earnings appropriated (REA):1||selective disclosure:1||separation of ownership from management:1||signaling:1||signaling theory:1||substance over form:1||timeliness of public disclosures:1||uncertainty of past earnings information:1||valuation:1||가결산결과의 사전공시:1||가결산순이익:1||가치평가:1||감리품질:1||감사보수:1||감사수요:1||감사실패:1||감사위원회:1||감사위원회 재무전문가:1||감사위험:1||감사인 지정:1||감사인등록제도:1||개별감사업무감리:1||거래전장부금액법:1||결산월 변경공시:1||결산월 변경동기:1||경영자 신호이론:1||경영자 예측정보:1||경영자 이익예측치:1||경제적 실질우선:1||공시기한 단축:1||공정가치:1||공정공시:1||공정공시제도:1||과거 이익정보의 불확실성:1||과대공시:1||과잉투자:1||관리종목:1||국내 개인투자자:1||국내 기관투자자:1||국내기관투자가:1||국제회계기준:1||금융감독원 모범사례:1||기술성장기업:1||기업가치:1||기업규모:1||기업회계기준서 제1호:1||기재유인:1||기회주의적 변경사유:1||내부자매수거래:1||내부정보신호가설:1||대규모기업집단:1||대리인 비용:1||대리인비용:1||대주주1인 지분율:1||동일지배:1||마일스톤 공시:1||매수법:1||모멘텀전략:1||목표주가:1||무보증회사채 신용등급:1||미래 주식수익률:1||발전방안:1||분기보고서 미비사항:1||비교가능성:1||비기대이익:1||비상장주식:1||비적정의견:1||사내유보이익:1||사업결합:1||사외이사의 대리인문제:1||사적이익동기가설:1||사후 감시기능:1||선별적인 정보제공:1||성장가능성:1||성장가능성.:1||성장목적적립금:1||소유와 경영의 분리:1||소유지배구조:1||손실대비적립금:1||시장효율성:1||신호역할:1||애널리스트:1||연구개발지출:1||영업성과:1||영업손익:1||영업손익의 공시:1||영업이익:1||영업활동:1||예측능력:1||예측능력의 지속성:1||의무적용:1||이사회 독립성:1||이익공시:1||이익공시일:1||이익의 질:1||이익지속성:1||이자와 배당수입:1||이자지급:1||임의적립금:1||자본화:1||장기차입:1||재무분석가:1||전문가적 의구심:1||전문경영자의 대리인문제:1||전문투자자지분:1||전유정보 공시비용이론:1||전자공시(DART)시스템:1||정기주총소집 공시일:1||정기주총일:1||정보불균형:1||정보비대칭이론:1||정보우위:1||정보효과:1||제약·바이오기업:1||주가반응의 선점 효과:1||지정사유:1||창립 40주년:1||코스닥기업:1||투표권:1||특기사항:1||품질관리수준:1||품질관리시스템:1||품질관리제도감리:1||한국채택국제회계기준(KIFRS):1||한국회계학회:1||합리적인 변경사유:1||해외종속기업:1||핵심항목:1||현금구매지분:1||현금배당:1||현금흐름 분류 유인:1||현금흐름표:1||확인역할:1||회계법인 특성:1||회계변경:1||회계분식:1||회계이익의 질:1||회계정보의 질:1||Accounting Transparency:1||회계투명성:1||Accounting reforms:1||Accrual models:1||Agency Cost:1||Agency costs:1||Analysts:1||Audit Firm Characteristics:1||Audit Quality:1||Audit committee financial experts:1||Audit fees:1||Audit services:1||Auditor Designation:1||Big 4 Auditor:1||Big 4 감사인:1||Big6 auditor:1||Cash Dividend:1||Cash flow rights:1||Cash flow statement:1||Comparability:1||Consolidated financial statements:1||Curtailment of Statutory Disclosure Period:1||DIVERGENT EXPECTATIONS:1||Debt Financing:1||Deficiencies in Quarterly Reports:1||Designation Criteria:1||Determinants of classifying cash flows:1||Disclosure of operating income:1||Discretionary Accruals:1||Discretionary accruals:1||Domestic individual investors:1||Domestic institutional investors:1||

STATISTICS: Total View :6,871,651; Today View :6,477

RSS_1.0 RSS_2.0 ATOM_1.0

84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE